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Experimental transmission of chronic wasting disease agent
from mule deer to cattle by the intracerebral route
Amir N. Hamir1, Robert A. Kunkle, Randall C. Cutlip, Janice M. Miller, Katherine I. O’Rourke,
Elizabeth S. Williams, Michael W. Miller, Mick J. Stack, Melanie J. Chaplin, Ju¨rgen A. Richt
Abstract. This communication reports final observations on experimental transmission of chronic wasting
disease (CWD) from mule deer to cattle by the intracerebral route. Thirteen calves were inoculated intracere-
brally with brain suspension from mule deer naturally affected with CWD. Three other calves were kept as
uninoculated controls. The experiment was terminated 6 years after inoculation. During that time, abnormal
prion protein (PrPres) was demonstrated in the central nervous system (CNS) of 5 cattle by both immunohis-
tochemistry and Western blot. However, microscopic lesions suggestive of spongiform encephalopathy (SE) in
the brains of these PrPres-positive animals were subtle in 3 cases and absent in 2 cases. Analysis of the gene
encoding bovine PRNP revealed homozygosity for alleles encoding 6 octapeptide repeats, serine (S) at codon
46, and S at codon 146 in all samples. Findings of this study show that although PrPres amplification occurred
after direct inoculation into the brain, none of the affected animals had classic histopathologic lesions of SE.
Furthermore, only 38% of the inoculated cattle demonstrated amplification of PrPres. Although intracerebral
inoculation is an unnatural route of exposure, this experiment shows that CWD transmission in cattle could
have long incubation periods (up to 5 years). This finding suggests that oral exposure of cattle to CWD agent,
a more natural potential route of exposure, would require not only a much larger dose of inoculum but also
may not result in amplification of PrPres within CNS tissues during the normal lifespan of cattle.
Key words: Cattle; chronic wasting disease (CWD) of mule deer; prion disease.
Chronic wasting disease (CWD), a prion disease, is a neu-
rodegenerative transmissible spongiform encephalopathy
(TSE) that has been identified in captive and free-ranging
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cervids.20 Chronic wasting disease has been transmitted ex-
perimentally by intracerebral inoculation of brain from mule
deer into a variety of animal species, including a goat.20 In
a previous publication, preliminary findings of an experi-
mental CWD inoculation into cattle through the intracerebral
route was reported.7 The present communication describes
the final results of that study, which was terminated in the
fall of 2003, 6 years after the study was initiated.
The primary objective of this study was to determine
whether the CWD agent could be transmitted to cattle by
intracerebral inoculation. Secondary objectives were to pro-
vide information to TSE researchers about the clinical course
and lesions of CWD in this species and to determine the
suitability of currently used TSE diagnostic procedures for
detection of CWD in cattle.
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Table 1. Findings in 13 cattle experimentally inoculated with a mule deer isolate of the CWD agent and in 3 uninoculated control
animals.
Year
PI*
Ear tag
No.
CWD
inoculation
Survival
period (mo)
Clinical
course
Clinical
signs
Histopathology
SE NAD IHC SAF WB
2 1745 i/c 23 2 mo 1 1/2 2 1 2 1
1768 i/c 24 3 mo 1 1/2 2 1 1 1
3 1732 control 26 NA 2 2 1/2 2 2 2
1744 i/c 28 3 days 1/2 2 2 1 1 1
4 1749 i/c 44 NA 2 2 2 2 NT 2
1748 i/c 45 NA 2 2 1 2 NT 2
5 1741 i/c 59 NA 2 2 2 2 NT 2
1743 i/c 59 NA 2 2 2 2 NT 2
1746 i/c 59 7 days 1/2 1/2 1 1 NT 1
6 1765 i/c 62 1 day 2 2 2 2 NT 2
1772 i/c 63 2 days 2 2 1 1 NT 1
1757 i/c 72 NA 2 2 1 2 NT 2
1760 i/c 72 NA 2 2 1 2 NT 2
1747 i/c 72 NA 2 2 1 2 NT 2
1730 control 72 NA 2 2 1 2 NT 2
1731 control 72 NA 2 2 1 2 NT 2
* PI 5 after intracerebral inoculation; SE 5 spongiform encephalopathy; NAD 5 neuroaxonal degeneration; NT 5 not tested; IHC 5
immunohistochemistry for PrPres; SAF 5 scrapie-associated fibrils; NA 5 not applicable; WB 5 Western blot (Prionics-Checka); 1 5
lesions or antigen present; 2 5 lesions or antigen absent; 1/2 5 signs/lesions equivocal; and i/c 5 intracerebral.
Sixteen 4–6-month-old calves of mixed breed (primarily
red and black Angus) were purchased from a herd of cattle
outside the CWD-endemic area14 and were assigned to in-
oculated (n 5 13) and control (n 5 3) groups. Inoculated
calves were housed in a Biosafety Level 2 isolation barn at
the National Animal Disease Center (NADC), Ames, Iowa.
Husbandry of these animals has been described previously.7
Personnel wore protective clothing while in the isolation fa-
cility and showered before leaving the facility.
Material for inoculation was prepared from a pool of 28
CWD-affected mule deer brains as described previously.2,3
The pool was positive for scrapie-associated fibrils (SAF) by
negative-stain electron microscopy and for PrPres by Western
blot (WB).7 In addition, the inoculum produced CWD infec-
tions in mule deer fawns after oral inoculation.7 Calves were
inoculated intracerebrally with 1 ml of the CWD brain in-
oculum as described previously.7 Three calves (controls)
were not inoculated.
Animals were euthanized with pentobarbital, and a com-
plete necropsy was conducted on each of the carcasses. Rep-
resentative samples of lung, liver, kidney, spleen, salivary
gland, thyroid gland, reticulum, rumen, omasum, abomasum,
intestines (ileum, colon), adrenal gland, pancreas, urinary
bladder, lymph nodes (retropharyngeal, prescapular, mesen-
teric, popliteal), tonsil, striated muscles (heart, tongue, mas-
seter, diaphragm), eye, sciatic nerve, trigeminal ganglion, pi-
tuitary gland, and spinal cord (cervical, thoracic, lumbar)
were immersion fixed in 10% neutral buffered formalin. The
brain was cut longitudinally, and half of the brain was fixed
in formalin and the remainder of the brain was frozen (220
C). The formalin-fixed brain was cut into 2–4-mm-wide cor-
onal sections. Sections of various anatomic sites (10–15 sec-
tions per animal) of cerebrum, cerebellum, brainstem (in-
cluding the obex), and spinal cord (cervical, thoracic, and
lumbar) were processed for routine histopathology, embed-
ded in paraffin wax, and sectioned at 5-mm. The sections
were stained with hematoxylin and eosin (HE), and by an
immunohistochemical (IHC) method8,13 for detection of
PrPres, with or without formic acid pretreatment. As de-
scribed previously,7 3 different antiPrP primary antibodies
were used, which included a rabbit polyclonal antibody and
2 monoclonal antibodies, F89/160.1.5 and F99/97.6.1,15,16
provided by one of the authors (KIO). The latter 2 antibodies
recognize PrP sequences conserved in most mammalian spe-
cies in which natural TSEs have been reported.15
For immunodetection of PrPres, a WB method18 was per-
formed on frozen brain (caudal medulla) using an antibody-
designated 6H4.a The SAFs were detected in fresh brain
(caudal medulla) using negative-stain electron microscopy.19
Genomic DNA was extracted from 3 ml of whole blood or
30 mg of spleen using a commercial kit.b Exon 3 of the bovine
PRNP gene was amplified using approximately 0.4 mg genomic
DNA in a final concentration of each of the following reagents:
2.5 mM MgCl2, 200 mM dNTP stock solution, 2.5 units of Taq
polymerase, and 0.2 mM each of forward primer (59 ggcatat-
gatgctgacacc) and reverse primer (59 tacggggctgcaggtagat).
Amplifications were performed at 95 C for 5.5 minutes, fol-
lowed by 30 cycles of 95 C (30 seconds), 62 C (30 seconds),
and 72 C (59 seconds), followed by an extension cycle (72 C,
7 minutes). Polymerase chain reaction (PCR) products were
analyzed on 1.5% agarose gels stained with ethidium bromide.
After treatment of PCR products with ExoSAPc both DNA
strands were sequenced at least once using nested forward (59
ctggggtcaaggtggtagcc) and reverse (59 tggtggtgactgtgtgttccttga)
primers using ABI Big Dye Terminator chemistryd by Ampli-
con Express.e
Within 2 years after intracerebral inoculation (PI), 2 ani-
mals (Nos. 1745 and 1768; Table 1) gradually became an-
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orexic and lost weight. At about the same time, 1 of these
animals (No. 1768) became apprehensive and circled aim-
lessly in its pen. The other (No. 1745) became listless but
was excited by loud noises. These behavioral changes con-
tinued with little variation until the animals were euthanized
8 and 14 weeks later. The altered behavior was subtle and
most obvious to the animals’ daily caretaker. Both animals
were found recumbent and were euthanized 23 and 24
months PI (Table 1). At that time, a control animal (No.
1732; Table 1) was also euthanized to obtain tissues for his-
topathology and to test for the presence of PrPres. A third
inoculated animal (No. 1744; Table 1) developed lameness
in 1 leg at approximately 27 months PI. Because it had over-
grown hooves, its feet were trimmed under general anesthe-
sia. Recovery was uneventful and the animal’s gait appeared
to improve. However, a week later, it was found recumbent
and was euthanized for humane reasons.
During years 4 and 5 PI, 5 additional inoculated animals
were euthanized (Table 1). Four had developed chronic leg
problems as a result of being kept on concrete floors. One
animal (No. 1746) became suddenly recumbent and because
of a poor prognosis was euthanized a week later. This animal
was found to have a fractured vertebra. Early in the sixth
year PI, 2 additional animals (Nos. 1765 and 1742; Table 1)
were found recumbent and were euthanized. The experiment
was terminated at the end of year 6 PI. At that time, the
remaining 3 inoculated and 2 control cattle, which appeared
clinically normal, were euthanized (Table 1).
At necropsy, 2 animals were emaciated (Nos. 1745 and
1768; Table 1), but other gross lesions were not evident.
Animal No. 1744 (Table 1), which was in a good body con-
dition, had a large (approximately 20 cm in diameter) pul-
monary abscess in 1 of the diaphragmatic lobes. The abscess
contained copious, thick, greenish purulent material that was
surrounded by a thick fibrous capsule. Significant lesions
were not observed in other inoculated or control animals
(Table 1).
Results of neurohistopathologic findings and the PrPres
tests are summarized in Table 1. Microscopic examination
of HE-stained brain and cervical cord sections revealed iso-
lated vacuolated neurons, a few degenerate axons, and mild
astrocytosis in 3 CWD-inoculated cattle (Nos. 1745, 1768,
and 1746; Table 1). However, vacuolated neurons were never
seen in either the dorsal vagal or the solitary tract nuclei.
Extensive neuroaxonal degeneration (NAD) was seen in the
medulla oblongata in specific nuclei of most older (more
than 5 years) cattle. The NAD involved nucleus Gracilis and
was also seen in the 2 control animals that were euthanized
at the termination of the study. One control animal (No.
1732) had moderate numbers of vacuolated neurons in the
red nucleus.
The PrPres was detected by IHC in the brains of 5 inocu-
lated cattle (Nos. 1745, 1768, 1744, 1746, and 1772; Table
1). The anatomic distribution and staining pattern was sim-
ilar with all 3 antibodies with or without formic acid treat-
ment of sections. The distribution of PrPres was widespread,
appearing predominantly in gray matter, in some areas of
white matter of the cervical spinal cord, and throughout the
brain, except in cerebellar folia. The greatest amount of
staining was present in the medulla oblongata and the mid-
brain. The staining pattern was multifocal (Fig. 1) and most
of the reactivity was concentrated in or around astrocytes
(Fig. 2). There was also scattered particulate or granular
staining in neuropil, and small plaques (up to 40 mm in di-
ameter) were occasionally observed. Staining in neuronal
cytoplasm was uncommon, and there was no perineuronal
or perivascular staining.
All other nonneuronal tissues, including the lymphoid tis-
sues (spleen, tonsil, lymph nodes, Peyer patches) were neg-
ative. The PrPres was not present in tissue sections of control
animals. The PrPres was also detected by WB analysis in
brain material from the 5 IHC-positive animals. A distinct
profile of the 3 isoforms of PrPres (diglycosylated, mono-
glycosylated, and unglycosylated polypeptides) is shown for
3 selected positive samples in Fig. 3. Fresh, frozen, or for-
malin-fixed brain tissues of 4 animals revealed SAFs in 2
animals (Nos. 1744 and 1768; Table 1).
Exon 3 of the bovine PRNP gene contains either 5, 6, or
7 copies of the octapeptide repeat region, 10 noncoding
changes, and 2 coding changes (S46I, S146N).12 Codon
numbering was based on the allele encoding 5 octapeptide
repeats. All cattle in this study were homozygous for alleles
encoding 6 octapeptide repeats, serine (S) at codon 46, and
S at codon 146. Noncoding changes were identified at co-
dons 78 (13 cattle homozygous for cag and 3 cattle hetero-
zygous for cag/caa), 105 (9 cattle homozygous for ccc and
7 heterozygous for ccc/cct), and 184 (10 cattle homozygous
for aac, 1 homozygous for aat, and 5 heterozygous cattle).
No polymorphisms were observed at any other sites. No dif-
ferences in PRNP were seen in cattle with or without PrPres.
Cross-species transmission experiments provide valuable
information for identification of potential host ranges of
known TSE agents. Chronic wasting disease, similar to all
other TSEs, is characterized by a long incubation period,
which in deer is seldom less than 18 months.20 In this study,
3 of the 5 cattle that were positive for PrPres died or were
euthanized 23–28 months PI; the other 2 animals that were
positive for PrPres survived longer (59 and 63 months PI).
In cervids, clinical CWD is characterized by emaciation,
changes in behavior, and excessive salivation.20 Although the
latter was not observed in the 5 PrPres-positive cattle de-
scribed in this study, 2 animals (Nos. 1745 and 1768; Table
1) developed reduced appetite and had considerable weight
loss approximately 2 years after inoculation, and their car-
casses were emaciated at necropsy. These animals also
showed subtle behavioral changes that were more obvious
to animal caretakers who had frequent contact with the an-
imals. The other 3 PrPres-positive cattle did not show clinical
signs, and whether their health problems were attributable to
inoculation or husbandry could not be discerned.
Although 5 animals were positive for PrPres by IHC and WB,
microscopic lesions of spongiform encephalopathy in this study
were either subtle (n 5 3) or absent (n 5 2) in these animals
(Table 1). In 2 of the animals, SAFs were also detected. These
findings indicate that domestic cattle are susceptible to CWD
by experimental intracerebral inoculation. However, they ap-
pear to be less susceptible to CWD than to the scrapie agent
as indicated by results from a previous experiment2,3 in which
100% of cattle inoculated intracerebrally with the US scrapie
agent died 14–18 months after inoculation and all were positive
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Figure 1. Brain; medulla oblongata of animal No. 1746. Multiple foci of PrPres staining (red) are present. Stained for PrPres by IHC. 643.
Figure 2. Brain; medulla oblongata of animal No. 1746. Higher magnification of area demarcated in Fig. 3 showing PrPres accumulations
located predominantly in or around astrocytes. Note absence of staining in or around the neurons. Stained for PrPres by IHC. 5123.
for PrPres. The comparatively lower susceptibility of cattle to
intracerebral CWD inoculation than to intracerebral scrapie in-
oculation is consistent with cell-free conversion findings that
PrPCWD was less efficient than PrPSc in converting bovine PrPc
to PrPres in vitro.17
In this experiment, the possibility that the PrPres seen in
tissue sections could be residual CWD material from the
inoculum was ruled out because of the multifocal distribu-
tion of PrPres throughout the brain (excluding cerebellar fo-
lia) and also in the cervical spinal cords of all 5 affected
animals. If it were residual inoculum, the PrPres would most
likely have been observed as locally extensive areas of PrPres
in the midbrain and cerebrum (site of inoculation). More-
over, in experimental studies with sheep scrapie, it has been
shown that intracerebrally inoculated brain material contain-
ing PrPres is present in large enough quantity to be detected
only during the first few days PI.9
Localization of PrPres accumulation in brains of CWD-
inoculated cattle was unusual because the pattern was mul-
tifocal and a primary target seemed to be astrocytes. Al-
though PrPres accumulation in astrocytes has been reported
in a study of early experimental scrapie in mice,4 this is not
a prominent feature of bovine spongiform encephalopathy
(BSE). The astrocytic pattern of IHC staining in CWD-in-
oculated cattle was also distinctly different from the PrPres
distribution observed in cattle inoculated intracerebrally with
brain homogenate from scrapie-affected sheep.2,3 In those an-
imals, PrPres was primarily concentrated in neuronal cyto-
plasm, a staining pattern that persisted even after second
passage in cattle.2 It is intriguing that 2 such different PrPres-
staining patterns are produced in cattle by intracerebral in-
oculation of TSE agents, depending on the source of inoc-
ulum (scrapie or CWD). Furthermore, these staining patterns
differ from those described with naturally acquired scrapie,
BSE, or CWD in their normal host species.6 In the respective
natural diseases, the IHC reactivity is described as a diffuse
particulate staining of gray matter neuropil, with occasional
plaques also being present in scrapie and CWD.6 The dif-
ferences in staining patterns produced by experimental BSE,
scrapie, and CWD in cattle could be useful in identifying a
likely exposure source(s), should new cases of prion disease
arise in North American cattle.
The WB analysis of brain material from CWD-inoculated
cattle revealed presence of the pathological form of the PrP,
PrPres, in 5 animals (Table 1; Fig. 3). As expected, all 3
isoforms (unglycosylated, monoglycosylated, and diglyco-
sylated polypeptides) of the PrPres were easily detected by
WB (Fig. 3). When PrPres from CWD-inoculated cattle was
compared in WBs with PrPres from mule deer CWD used for
cattle inoculation, a lower molecular weight of the ungly-
cosylated PrP polypeptide of the cattle-passaged CWD com-
pared with the mule deer CWD was noted (data not shown).
Degenerative changes that were confined to the caudal
medulla of both experimental and control cattle were com-
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Figure 3. Western blot (with 6H4 antibody) showing distinct
profile of PrPres in the 3 positive animals Nos. 1742, 1745, and 1746.
No signal is seen in No. ns1765, a noninoculated animal, classified
as WB negative. A molecular-weight marker is shown in the first
lane and a positive scrapie control is shown in the third lane.
patible with a diagnosis of NAD. Most of the affected ani-
mals were older than 5 years (Table 1) which suggests that
the condition is probably a progressive one and is not ob-
served until the animals are older. Among animals, naturally
occurring NAD has been described in cats, dogs, cattle,
sheep, horses, and raccoons.5,10 Such lesions have been as-
sociated with the normal aging process, as well as degen-
erative diseases and experimental conditions.11 Therefore,
factors other than age (such as genetic, nutritional, and en-
vironmental) may have an influence on such degenerative
axonal changes in the central nervous system of cattle.
The results in this study show that although PrPres was
able to amplify in only 5 of 13 (38%) cattle, the resulting
PrPres was easily detected by all 3 laboratory tests (IHC, WB,
SAF). In addition, the IHC pattern of PrP deposition was
rather unique (multifocal distribution and within small astro-
cytic type cells). Therefore, it appears that the diagnostic
tests (IHC, WB) used at this time for confirmation of BSE
cases in the United States would allow recognition of CWD
in cattle, should it occur here.
Although intracerebral inoculation is an unnatural route
for exposure of cattle to CWD infection, this experiment
shows that CWD, similar to scrapie, has some potential for
transmission to this species. Unlike scrapie in sheep, there
does not appear to be any genetic predisposition in cattle for
BSE, and in this study no difference was seen in the PrP
gene of animals with or without PrPres after CWD inocula-
tion. The CWD isolates from other cervids (white-tailed deer
and elk) may differ in their ability to amplify in cattle, and
therefore, transmission studies using different CWD isolates
are required. Such experiments will be initiated in the near
future at the NADC (Ames, IA).
It is likely that transmission of CWD to cattle by natural-
exposure routes, such as per os or by contact on range with
infected cervids, would be more difficult to accomplish than
the intracerebral transmissions reported here. Two experi-
ments are currently in progress in Wyoming and Colorado,
and approximately 7 years into these studies cattle orally or
naturally exposed to CWD remain healthy (Williams, per-
sonal communication). On the basis of the results of this
study, and on data obtained from 2 previous cross-species
transmission studies (sheep-scrapie transmission to cattle by
intracerebral and oral routes),1,2 it may be concluded that
under natural conditions cattle exposed to CWD would re-
quire a large dose of inoculum and also an extremely long
incubation time to develop a TSE-associated disease. A sec-
ond cattle passage with brain tissue from this study (infected
with CWD from mule deer) may produce TSE-related dis-
ease in a larger proportion of inoculated animals in a shorter
time and probably an altered clinicopathological picture of
the disease. Such a study is now in progress at this Center.
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Naturally occurring Eastern Equine Encephalitis in a Hampshire wether
Rudy W. Bauer1, Marjorie S. Gill, Rob P. Poston, Dae Young Kim
Abstract. Eastern equine encephalitis (EEE) was diagnosed (postmortem) in a sheep with clinical signs
attributable to a central nervous system disease. The sheep was febrile and initially had front limb incoordi-
nation, which progressed to paralysis of both front and hind limbs during a course of 2 days. The sheep
maintained an alert attitude with the ability to eat up to the time of euthanasia. The only clinical pathologic
abnormalities were neutrophilia and lymphopenia without appreciable leukocytosis, a moderate hyperglycemia,
and an elevated creatine kinase. Treatment included hydrotherapy for lowering body temperature, intravenous
fluids, thiamine hydrochloride, tetanus antitoxin, antibiotics, and corticosteroids. The only gross lesion at the
time of necropsy was a wet glistening surface of the brain (leptomeninges). Microscopically, there was severe
nonsuppurative meningoencephalitis, poliomyelitis, and polyradiculoneuritis with mild multifocal neutrophilic
infiltration. The EEE virus was isolated from the brain, and subsequent fluorescent antibody testing for EEE
was positive on cell culture.
Key words: Alphavirus; arbovirus; eastern equine encephalitis; meningoencephalitis; sheep.
A 5-month-old, 45-kg Hampshire show wether was pre-
sented for emergency care with a complaint of incoordina-
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tion of the front legs. The lamb had reportedly been normal
the day before presentation and had been shown at a local
lamb show. The lamb ate normally the morning of presen-
tation and although was having difficulty using the front
legs, could stand and walk with assistance. Within 3 hours
of showing the first clinical signs, the lamb was unable to
stand without assistance or stay in sternal recumbency but
was still alert, responsive, and had a good appetite. The lamb
had been housed with another lamb; both had access to a
grass pasture, were fed a pelleted sheep feed, and were sup-
